1. Home
  2. HUN vs EWTX Comparison

HUN vs EWTX Comparison

Compare HUN & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUN
  • EWTX
  • Stock Information
  • Founded
  • HUN 1970
  • EWTX 2017
  • Country
  • HUN United States
  • EWTX United States
  • Employees
  • HUN N/A
  • EWTX N/A
  • Industry
  • HUN Major Chemicals
  • EWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUN Industrials
  • EWTX Health Care
  • Exchange
  • HUN Nasdaq
  • EWTX Nasdaq
  • Market Cap
  • HUN 2.9B
  • EWTX 2.7B
  • IPO Year
  • HUN 2005
  • EWTX 2021
  • Fundamental
  • Price
  • HUN $17.70
  • EWTX $27.07
  • Analyst Decision
  • HUN Hold
  • EWTX Buy
  • Analyst Count
  • HUN 8
  • EWTX 7
  • Target Price
  • HUN $21.63
  • EWTX $42.71
  • AVG Volume (30 Days)
  • HUN 3.1M
  • EWTX 950.6K
  • Earning Date
  • HUN 02-17-2025
  • EWTX 02-28-2025
  • Dividend Yield
  • HUN 5.66%
  • EWTX N/A
  • EPS Growth
  • HUN N/A
  • EWTX N/A
  • EPS
  • HUN N/A
  • EWTX N/A
  • Revenue
  • HUN $6,036,000,000.00
  • EWTX N/A
  • Revenue This Year
  • HUN $5.07
  • EWTX N/A
  • Revenue Next Year
  • HUN $5.33
  • EWTX N/A
  • P/E Ratio
  • HUN N/A
  • EWTX N/A
  • Revenue Growth
  • HUN N/A
  • EWTX N/A
  • 52 Week Low
  • HUN $15.67
  • EWTX $14.90
  • 52 Week High
  • HUN $27.01
  • EWTX $38.12
  • Technical
  • Relative Strength Index (RSI)
  • HUN 59.13
  • EWTX 48.74
  • Support Level
  • HUN $16.50
  • EWTX $24.92
  • Resistance Level
  • HUN $18.53
  • EWTX $29.14
  • Average True Range (ATR)
  • HUN 0.65
  • EWTX 1.64
  • MACD
  • HUN 0.19
  • EWTX 0.01
  • Stochastic Oscillator
  • HUN 83.74
  • EWTX 38.67

About HUN Huntsman Corporation

Huntsman Corp is a us-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives most of its revenue from the Polyurethanes segment which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.

Share on Social Networks: